	Guanylate-binding proteins score and a CBFA2T3-included risk model define immune microenvironment and chemosensitivity in lung adenocarcinoma. Eur J Med Res Shi Z, Shen Y, Liu X, Zhang S. PMID: 41419978 [PubMed - as supplied by publisher]
	Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer. BMC Cancer Yano R, Tokito T, Murotani K, Murata D, Tsuneyoshi S, Ishii H, Azuma K, Hoshino T. PMID: 41419873 [PubMed - as supplied by publisher]
	Clinical impact of continuing osimertinib beyond progression versus best supportive care in EGFR-mutated advanced non-small cell lung cancer: a multi-institutional retrospective study. BMC Cancer Oi I, Fujita K, Imakita T, Okada Y, Yoshimura S, Fujimoto N, Toyama S, Watanabe A, Ito T, Kaku R, Kanai O, Ohuchi M, Noguchi T, Tsukino M, Sawai S, Tanizawa K. PMID: 41419830 [PubMed - as supplied by publisher]
	Harnessing Native-Resolution 2D Embeddings for Lung Cancer Classification: A Feasibility Study with the RAD-DINO Self-supervised Foundation Model. J Imaging Inform Med Hoq ME, Tarbox L, Johann D Jr, Larson-Prior L, Prior F. PMID: 41419702 [PubMed - as supplied by publisher]
	Consensus on the Diagnosis and Treatment of Unresectable Stage III Driver Gene-Positive Non-Small Cell Lung Cancer. Cancer Lett Meng X, Bi N, Wang J, Meng X, Wang J, Xing L, Cheng Y, Lu S, Chen M, Yu J, Chinese Society of Clinical Oncology (CSCO) Radiation Therapy Expert Committee, Consensus Expert Group. PMID: 41419100 [PubMed - as supplied by publisher]
	Optimizing adjuvant therapy under the guidance of MPR: A multicenter retrospective analysis of neoadjuvant therapy in non-small cell lung cancer. Eur J Surg Oncol Chen C, Chen J, Huang J, He LP, Shen YM, Tu JH, Lian LY, Jin ZW, Wang HJ, Wang ZJ, Luo YF, Sun ZM, Ye MQ, Shen GY, Xu SJ, Chen SC. PMID: 41418573 [PubMed - as supplied by publisher]
	What is on the Horizon Beyond Platinum and Immunotherapy for Patients With Advanced Non-Small Cell Lung Cancer Without Actionable Genomic Aberrations? JCO Oncol Pract Ribeiro Rangel A, Cavalcante Lima Chagas G, Cavalcante Lima Chagas R, El Osta B. PMID: 41418081 [PubMed - as supplied by publisher]
	Cost-Effectiveness Analysis of Durvalumab in Limited-Stage Small Cell Lung Cancer in the United States. JCO Glob Oncol Jani CT, Manoharan A, Han S, Zheng X, Malik S, Morgenstern-Kaplan D, Salazar AS, Kareff S, Lopes G. PMID: 41418077 [PubMed - indexed for MEDLINE]
	Ablation versus sublobar resection for stage IA non-small cell lung cancer: a multicenter retrospective cohort study using a deep learning model in the ablation group. Int J Surg Xu B, Huang D, Liu D, Huang T, Chen Z, Zhu Z, Lin L, Zhang F. PMID: 41418024 [PubMed - as supplied by publisher]
	A novel prognostic model for lung squamous cell carcinoma based on multi-omics analysis and machine learning. PLoS One Li J, Shen Z, Liu D, Ma J. PMID: 41417784 [PubMed - indexed for MEDLINE]
	Peripheral TERT- positive leukocytes as a biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progression. Mol Biomed Zhang Q, Zhang X, Li G, Yuan L, Wan D, Xie P, Cheng S, Zhang Y, Zhang K, Mao Y, Zhang W. PMID: 41417416 [PubMed - indexed for MEDLINE]
	Global trends, risk factors, and therapeutic associations of fungal pulmonary infections in lung cancer: A systematic review and meta-analysis. J Bras Pneumol Sheervalilou M, Ghanei M, Arabfard M. PMID: 41417303 [PubMed - indexed for MEDLINE]
	Effects of behavioural speech therapy on postoperative cough and cough-related quality of life of lung cancer patients undergoing thoracoscopic surgery: A prospective randomized controlled study. Support Care Cancer Jin Y, Song X, Liu C, Xi Z, Zhang H, Chen C, Hu Z, Tian Y. PMID: 41417244 [PubMed - indexed for MEDLINE]
	Integrating differential gene expression and Mendelian randomization analyses reveal novel gene for prognosis, immune response, and drug sensitivity in lung cancer. Discov Oncol Li M, Tang W, Li L, Le VMH, Zhang H, Zhao H, Lin Z, Han Y. PMID: 41417205 [PubMed - as supplied by publisher]
	CT findings of lung injury during breast cancer treatment. Breast Cancer Yamaguchi K, Egashira R, Nakazono T, Yoshinaga Y, Baba K, Kataoka M, Yabuuchi H, Aoki T, Togao O. PMID: 41417148 [PubMed - as supplied by publisher]
	Does pre-checkpoint inhibitor sarcopenia, visceral, or subcutaneous fat predict survival in non-small cell lung cancer patients? Support Care Cancer Kooser J, Davis M, Guo T, Vanenkevort E, Young A, Koppenhaver N, Lagerman B, Gupta M, Patel A, Wojtowicz M. PMID: 41417096 [PubMed - indexed for MEDLINE]
	Acupuncture reduced incidence of insomnia symptoms in patients with lung cancer: a retrospective cohort study. Support Care Cancer Yu R, Guo X, Zhu Y, Chen Y, Zhang C, Chai X, Wang Y. PMID: 41417088 [PubMed - indexed for MEDLINE]
	Interpretable machine learning model integrating CT radiomics, CTR, and clinical features for EGFR mutation prediction in ≤3 cm lung adenocarcinoma nodules. Ann Med Cai W, Liu Y, Zhao K, Zhu Z, Jin J, Han H, Hu M, Qiu X, Wen J, Xue Z. PMID: 41417019 [PubMed - indexed for MEDLINE]
	Factors Influencing the Effectiveness of Fluorescence in Determining the Intersegmental Plane During Intentional Pulmonary Segmentectomy: Results of a Prospective Study on 196 Patients. Thorac Cancer Rudondy Q, Martinet-Kosinski F, Benkiran T, Cohen C, Gomez-Caro A, Frey S, Berthet JP. PMID: 41416845 [PubMed - indexed for MEDLINE]
	IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer. Cancer Sci Okada M, Sugawara S, Watanabe Y, Saito H, Chen-Yoshikawa TF, Goto Y, Nishio W, Nakagawa S, Hayashi M, Kenmotsu H. PMID: 41416818 [PubMed - as supplied by publisher]

Articles 1 - 20 / 155877

Page 1 of 7794



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy